has tirzepatide been approved by the fda Is Approved? Approval Status & Clinical Use – PlexusDx Zepbound (tirzepatide) FDA Approval History

Ultimately, GLP-1based adjunct therapy in type 1 diabetes should be viewed as a personalized option rather than a standard treatment

Specific scenarios where Mounjaro might be considered include: Insufficient weight loss : Patients who have not achieved expected weight loss by 1218 months post-operatively despite adherence to dietary and lifestyle recommendations (some services use thresholds such as 50% excess weight loss, though criteria vary) Weight regain : Individuals experiencing significant weight regain after initial successful weight loss Persistent type 2 diabetes : Patients whose diabetes has not achieved remission or adequate control following surgery, particularly if weight loss has been suboptimal Weight loss plateau : Those who have reached a plateau well above their target weight despite continued adherence to behavioural modifications Before considering Mounjaro, your bariatric team will typically conduct a comprehensive reassessment including evaluation of dietary adherence, physical activity levels, psychological factors affecting eating behaviours, and potential surgical complications such as gastric sleeve dilation

Healthspans membership provides access to licensed clinicians and PhD-trained health experts who interpret labs, guide dosing decisions, and help mitigate side effects

That's my mandate, right

Comprehensive assessment for DSPN involves evaluating small and large fiber function through temperature/pinprick sensation and 128-Hz tuning fork vibration sensation, respectively, along with 10-g monofilament testing to identify feet at risk of ulceration and amputation [46]